Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3080% below fair value
$6.61−0.15 (-2.22%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Rockwell Medical profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Rockwell Medical's profit margin for the twelve months ending Jun 30, 2026 was -7.3%. For fiscal 2025 it was -7.7%, against -0.5% the year before. The highest annual figure on record is -0.5% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -7.7% | −7.2 |
| FY2024 | Dec 31, 2024 | -0.5% | +9.6 |
| FY2023 | Dec 31, 2023 | -10.1% | +15.6 |
| FY2022 | Dec 31, 2022 | -25.7% | +27.1 |
| FY2021 | Dec 31, 2021 | -52.8% | −3.1 |
| FY2020 | Dec 31, 2020 | -49.7% | +6.0 |
| FY2019 | Dec 31, 2019 | -55.7% | −5.0 |
| FY2018 | Dec 31, 2018 | -50.7% | −5.4 |
| FY2017 | Dec 31, 2017 | -45.2% | −8.1 |
| FY2016 | Dec 31, 2016 | -37.2% | −11.1 |
| FY2015 | Dec 31, 2015 | -26.1% | +13.3 |
| FY2014 | Dec 31, 2014 | -39.4% | +53.8 |
| FY2013 | Dec 31, 2013 | -93.1% | +15.3 |
| FY2012 | Dec 31, 2012 | -108.4% | −64.6 |
| FY2011 | Dec 31, 2011 | -43.8% | −39.3 |
| FY2010 | Dec 31, 2010 | -4.5% | +5.5 |
| FY2009 | Dec 31, 2009 | -10.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -6.6% | +2.7 |
| Q1 FY2026 | Mar 31, 2026 | -9.3% | −1.2 |
| Q4 FY2025 | Dec 31, 2025 | -3.0% | +0.0 |
| Q3 FY2025 | Sep 30, 2025 | -11.0% | −16.9 |
| Q2 FY2025 | Jun 30, 2025 | -9.3% | −10.6 |
| Q1 FY2025 | Mar 31, 2025 | -8.0% | −0.4 |
| Q4 FY2024 | Dec 31, 2024 | -3.1% | +3.8 |
| Q3 FY2024 | Sep 30, 2024 | 5.9% | +13.8 |
| Q2 FY2024 | Jun 30, 2024 | 1.3% | +19.6 |
| Q1 FY2024 | Mar 31, 2024 | -7.6% | +1.3 |
| Q4 FY2023 | Dec 31, 2023 | -6.8% | +5.4 |
| Q3 FY2023 | Sep 30, 2023 | -7.9% | +14.5 |
| Q2 FY2023 | Jun 30, 2023 | -18.3% | +8.3 |
| Q1 FY2023 | Mar 31, 2023 | -8.9% | +35.5 |
| Q4 FY2022 | Dec 31, 2022 | -12.2% | +46.1 |
| Q3 FY2022 | Sep 30, 2022 | -22.4% | +25.0 |
| Q2 FY2022 | Jun 30, 2022 | -26.6% | +28.9 |
| Q1 FY2022 | Mar 31, 2022 | -44.4% | +5.7 |
| Q4 FY2021 | Dec 31, 2021 | -58.3% | −1.2 |
| Q3 FY2021 | Sep 30, 2021 | -47.4% | +0.7 |
| Q2 FY2021 | Jun 30, 2021 | -55.5% | −12.1 |
| Q1 FY2021 | Mar 31, 2021 | -50.1% | +0.2 |
| Q4 FY2020 | Dec 31, 2020 | -57.1% | −10.0 |
| Q3 FY2020 | Sep 30, 2020 | -48.1% | +2.9 |
| Q2 FY2020 | Jun 30, 2020 | -43.4% | +26.0 |
| Q1 FY2020 | Mar 31, 2020 | -50.4% | +5.4 |
| Q4 FY2019 | Dec 31, 2019 | -47.1% | +8.5 |
| Q3 FY2019 | Sep 30, 2019 | -51.0% | −21.2 |
| Q2 FY2019 | Jun 30, 2019 | -69.3% | +12.7 |
| Q1 FY2019 | Mar 31, 2019 | -55.8% | −18.7 |
| Q4 FY2018 | Dec 31, 2018 | -55.6% | +5.3 |
| Q3 FY2018 | Sep 30, 2018 | -29.8% | +4.8 |
| Q2 FY2018 | Jun 30, 2018 | -82.0% | −28.5 |
| Q1 FY2018 | Mar 31, 2018 | -37.1% | −4.6 |
| Q4 FY2017 | Dec 31, 2017 | -60.9% | −23.2 |
| Q3 FY2017 | Sep 30, 2017 | -34.6% | +1.0 |
| Q2 FY2017 | Jun 30, 2017 | -53.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -32.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -37.7% | – |
| Q3 FY2016 | Sep 30, 2016 | -35.6% | – |
See a number that looks wrong?